$NOVO B #Novo Nordisk A/S B Novo Nordisk (Buy, TP: DKK560.00) - Evaluating the long term: We have analysed Novo Nordisk’s long-term growth opportunities in the expansion to other serious chronic diseases, as well as the organic growth… #equity #stocks
Trading Ideas: NOVO NORDISK B A/S long hours 📈 FREE trade-of-week via ⟶
Novo Nordisk's high-dose Ozempic stalls at FDA's door on lack of manufacturing data
$NOVO B #Novo Nordisk A/S B Novo Nordisk - ABGSC’s Danish large cap seminar feedback: Pandemic impacts persist, but glimpses of improvement Still a solid long-term growth story with upside potential Novo remains one of our preferred… #equity #stocks
Insulin is still expensive because the three major producers — Novo Nordisk, Eli Lilly and Sanofi — have been granted patents on the drug as they have incrementally changed it. With each small advance, the price has gone up
How cycling's novo nordisk'>Team Novo Nordisk turned type 1 diabetes into its "greatest strength"
People are dying or getting sicker because they can’t afford their insulin, just so Eli Lilly and Novo Nordisk can make outrageous profits.
Novo Nordisk to offer free insulin to U.S. patients in immediate need
Eli Lilly and Novo Nordisk clearly care more about their profits than their patients. It's time to end their greed.